866-997-4948(US-Canada Toll Free)

BSD Medical Corporation (BSDM) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 52 Pages


BSD Medical Corporation (BSD) is a medical device company. It designs, develops, manufactures and markets service systems for the treatment of cancer and other diseases using heat therapy using focused radio frequency and microwave energy. The product portfolio of company includes ablation systems including MicroThermX-180; and Hyperthermia Systems such as BSD-500, BSD-2000, BSD-2000/3D. BSD-500 is used to treat certain cancers located near the surface of the body. The BSD-2000 System is used to non-invasively treat certain deep cancers. MicroThermX MTX-180, has been developed to use precision-guided microwave energy to ablate soft tissue. The product line for cancer therapy offers hospitals and clinics a complete solution for thermal treatment of cancer using microwave/RF systems. BDS markets its products in the US, Europe and Asia through a network of sales representatives and distributors. The company is headquartered in Utah, the US.

It aims to commercialize the cancer treatment systems to treat cancers of the prostate, breast, head, neck, bladder, cervix, colon/rectum, ovaries, esophagus, liver, kidney, brain, bone, stomach and lung. The company in collaboration with leading distributors and sales representatives increasing the sales activities for MicroThermX.

This report is a source for data, analysis and actionable intelligence on the BSD Medical Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

BSD Medical Corporation - Business Description 6

Key Facts 7
BSD Medical Corporation - Major Products and Services 8
BSD Medical Corporation Pipeline Products by Equipment Type 9
BSD Medical Corporation Pipeline Products by Development Stage 11
BSD Medical Corporation Pipeline Products by Therapy Area 13
BSD Medical Corporation Pipeline Products by Trial Phase 15
BSD Medical Corporation Pipeline Products by Milestone Summary 17
BSD-2000 - Bladder Cancer 20
BSD-2000 - Bladder Cancer Product Status 20
BSD-2000 - Bladder Cancer Product Description 20
BSD-2000 - Bladder Cancer Clinical Trial 20
BSD-2000 - Non-small Cell Lung Cancer 23
BSD-2000 - Non-small Cell Lung Cancer Product Status 23
BSD-2000 - Non-small Cell Lung Cancer Product Description 23
BSD-2000 - Non-small Cell Lung Cancer Clinical Trial 23
BSD-2000 - Pancreatic Cancer 25
BSD-2000 - Pancreatic Cancer Product Status 25
BSD-2000 - Pancreatic Cancer Product Description 25
BSD-2000 - Pancreatic Cancer Product Milestone 25
BSD-2000 - Pancreatic Cancer Clinical Trial 26
BSD-2000 - Prostate Cancer 29
BSD-2000 - Prostate Cancer Product Status 29
BSD-2000 - Prostate Cancer Product Description 29
BSD-2000 - Rectal Cancer 30
BSD-2000 - Rectal Cancer Product Status 30
BSD-2000 - Rectal Cancer Product Description 30
BSD-2000 - Soft Tissue Sarcoma Cancer 31
BSD-2000 - Soft Tissue Sarcoma Cancer Product Status 31
BSD-2000 - Soft Tissue Sarcoma Cancer Product Description 31
BSD-2000 - Soft Tissue Sarcoma Cancer Product Milestone 31
BSD-2000 - Soft Tissue Sarcoma Cancer Clinical Trial 32
BSD-2000/3D 35
BSD-2000/3D Product Status 35
BSD-2000/3D Product Description 35
BSD-2000/3D Product Milestone 35
BSD-2000/3D Clinical Trial 36
BSD-2000/3D/MR 38
BSD-2000/3D/MR Product Status 38
BSD-2000/3D/MR Product Description 38
BSD-2000/3D/MR Product Milestone 38
BSD-2000/3D/MR Product Patent Details 39
BSD-500 Hyperthermia System 41
BSD-500 Hyperthermia System Product Status 41
BSD-500 Hyperthermia System Product Description 41
BSD-500 Hyperthermia System Product Milestone 41
BSD-500 Hyperthermia System Product Patent Details 42
BSD Medical Corporation - Key Competitors 44
BSD Medical Corporation - Key Employees 45
BSD Medical Corporation - Key Employee Biographies 46
BSD Medical Corporation - Locations And Subsidiaries 47
Head Office 47
Recent Developments 48
BSD Medical Corporation, Recent Developments 48
Nov 19, 2012: BSD Medical Reports Growing Interest In Hyperthermia Systems At 2012 ASTRO Meeting 48
Nov 14, 2012: BSD Medical Reports Revenue Of $2.1m In Fiscal 2012 48
Oct 18, 2012: BSD Medical Signs Exclusive Agreement With ADA Medikal For Distribution Of MicroThermX Microwave Ablation Line Of Products In Turkey 49
Oct 09, 2012: BSD Medical Reports 391% Increase In Sales For MicroThermX Product Line For September 2012 49
Oct 04, 2012: BSD Medical Presents Line Of Hyperthermia Systems At ICHO And Joint Japanese Congress of Thermal Medicine 49
Aug 22, 2012: BSD Medical Obtains Marketing Approval In Russian Federation For Hyperthermia Systems 49
Jul 06, 2012: BSD Medical Reports Q3 Fiscal 2012 Results 50
May 31, 2012: BSD Medical Reports International Scientists Organize To Advance Hyperthermia As Standard Cancer Treatment In Combination With Radiation And Chemotherapy 50
May 21, 2012: BSD Introduces New Microwave Ablation Products Into International Market At ECIO, Italy 51
Apr 06, 2012: BSD Medical Reports Q2 Fiscal 2012 Results 51

Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Table


BSD Medical Corporation, Key Facts 1
BSD Medical Corporation Key Pipeline Products by Equipment Type 1
BSD Medical Corporation Key Pipeline Products by Therapy Area 1
BSD Medical Corporation Key Pipeline Products by Development Stage 1
BSD Medical Corporation Key Pipeline Products by Trial Phase 1
BSD Medical Corporation, Key Facts 7
BSD Medical Corporation, Major Products and Services 8
BSD Medical Corporation Number of Pipeline Products by Equipment Type 9
BSD Medical Corporation Pipeline Products by Equipment Type 10
BSD Medical Corporation Number of Pipeline Products by Development Stage 11
BSD Medical Corporation Pipeline Products by Development Stage 12
BSD Medical Corporation Number of Pipeline Products by Therapy Area 13
BSD Medical Corporation Pipeline Products by Therapy Area 14
BSD Medical Corporation Number of Pipeline Products by Trial Phase 15
BSD Medical Corporation Pipeline Products by Trial Phase 16
BSD Medical Corporation Number of Pipeline Products By Milestone Summary 17
BSD Medical Corporation Pipeline Products by Milestone Summary 18
BSD-2000 - Bladder Cancer - Product Status 20
BSD-2000 - Bladder Cancer - Product Description 20
BSD-2000 - Bladder Cancer - Pilot Study of External Hyperthermia and Intravesical Mitomycin-C To Treat Recurrent Bladder Cancer After Resection and Standard Adjuvant Therapy 20
BSD-2000 - Non-small Cell Lung Cancer - Product Status 23
BSD-2000 - Non-small Cell Lung Cancer - Product Description 23
BSD-2000 - Non-small Cell Lung Cancer - BSD2000 Deep Hyperthermia Combined With Chemotherapy Of PT Regimen In Patients With Non-small Cell Lung Cancer 23
BSD-2000 - Pancreatic Cancer - Product Status 25
BSD-2000 - Pancreatic Cancer - Product Description 25
BSD-2000 - Pancreatic Cancer - Product Milestone 25
BSD-2000 - Pancreatic Cancer - Hyperthermia combined with radiochemotherapy in unresectable locally or recurrent advanced pancreatic cancer, a Phase II perspective study 26
BSD-2000 - Pancreatic Cancer - Phase III BSD-2000 Hyperthermia System-Chemotherapy Combination Study For Pancreatic Cancer Initiated 27
BSD-2000 - Pancreatic Cancer - A Randomized, Multicenter, Phase III Hyperthermia European Adjuvant Trial (HEAT) 28
BSD-2000 - Prostate Cancer - Product Status 29
BSD-2000 - Prostate Cancer - Product Description 29
BSD-2000 - Rectal Cancer - Product Status 30
BSD-2000 - Rectal Cancer - Product Description 30
BSD-2000 - Soft Tissue Sarcoma Cancer - Product Status 31
BSD-2000 - Soft Tissue Sarcoma Cancer - Product Description 31
BSD-2000 - Soft Tissue Sarcoma Cancer - Product Milestone 31
BSD-2000 - Soft Tissue Sarcoma Cancer - A phase II Trial Testing The Thermal Dose Parameter CEM43 Degrees T90 As A Predictor Of Response In Soft Tissue Sarcomas Treated With Pre-Operative Thermoradiotherapy 32
BSD-2000/3D - Product Status 35
BSD-2000/3D - Product Description 35
BSD-2000/3D - Product Milestone 35
BSD-2000/3D - Hyperthermia Therapy In Combination With Radiation And Chemotherapy Bladder Removal For The Treatment Of Bladder Cancer Patients 36
BSD-2000/3D/MR - Product Status 38
BSD-2000/3D/MR - Product Description 38
BSD-2000/3D/MR - Product Milestone 38
BSD-2000/3D/MR - Patent Details1 39
BSD-2000/3D/MR - Patent Details2 40
BSD-500 Hyperthermia System - Product Status 41
BSD-500 Hyperthermia System - Product Description 41
BSD-500 Hyperthermia System - Product Milestone 41
BSD-500 Hyperthermia System - Patent Details1 42
BSD-500 Hyperthermia System - Patent Details2 43
BSD Medical Corporation, Key Employees 45
BSD Medical Corporation, Key Employee Biographies 46

List of Chart


BSD Medical Corporation Pipeline Products by Equipment Type 9
BSD Medical Corporation Pipeline Products by Development Stage 11
BSD Medical Corporation Pipeline Products by Therapy Area 13
BSD Medical Corporation Pipeline Products by Trial Phase 15
BSD Medical Corporation Pipeline Products by Milestone Summary 17

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *